Todd Harris, Chief Executive Officer at Tyra Biosciences, Inc. (TYRA), sold 148,620 shares at $17.71 ($2.5M) on 2023-06-21, disclosed to the SEC on 2023-06-21.
Scheduled sale ($2.5M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.49 | 3,316 | $55K | 2.2% |
| 2 | $16.49 | 3,316 | $55K | 2.2% |
| 3 | $17.06 | 50,838 | $867K | 34.1% |
| 4 | $17.06 | 50,838 | $867K | 34.1% |
| 5 | $18.50 | 600 | $11K | 0.4% |
| 6 | $16.53 | 1,300 |
| $21K |
| 0.8% |
| 7 | $16.12 | 4,629 | $75K | 2.9% |
| 8 | $16.12 | 4,629 | $75K | 2.9% |
| 9 | $17.71 | 14,027 | $248K | 9.8% |
| 10 | $17.71 | 14,027 | $248K | 9.8% |
| 11 | $18.18 | 1,100 | $20K | 0.8% |
| Total | $17.11 avg | 148,620 | $2.5M | 100% |
| Filing → |
| TYRA | SELL | 2024-10-02 | $12K | — | Filing → |
| TYRA | SELL | 2024-09-25 | $527K | — | Filing → |
| TYRA | SELL | 2024-09-20 | $704K | — | Filing → |